Quantcast

Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
November 25, 2014, 11:22:55 PM

Login with username, password and session length


Members
Stats
  • Total Posts: 647439
  • Total Topics: 49334
  • Online Today: 259
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Varying efficacy of HIV drug cocktails explained  (Read 1352 times)

0 Members and 1 Guest are viewing this topic.

Offline John2038

  • Member
  • Posts: 1,529
  • Happiness is a journey, not a destination.
    • HIV Research News (Twitter)
Varying efficacy of HIV drug cocktails explained
« on: July 16, 2011, 04:46:36 PM »
Increasing dose works at critical times in virus’s life cycle

Slightly boosting the dose of some HIV drugs has a profound effect if those drugs are attacking multiple targets, the new model reveals.

For centuries, drug effectiveness has been visualized with what’s called the dose-response curve. This relationship often takes on a stretched-out “S” shape when graphed.

But in 2008, Siliciano’s then graduate student Lin Shen realized that the steepness of the incline of the “S” — its slope — varied with different classes of HIV drugs. A gradual climb meant that increases in drug concentration gradually improved the response. But a very steep slope meant that tiny increases in a drug’s concentration could wipe out significantly more target molecules.

That the steepness of this slope mattered for HIV drugs was puzzling, says Siliciano.  “The differences were huge — orders of magnitude,” he says.

For example, increasing the dose of the most effective protease inhibitors, drugs that block an HIV protein that snips up virus parts for assembly, can make them billions of times more powerful against the virus, he says. But increasing the amount of the drug AZT, which attacks virus machinery that translates genetic material, might yield an effect only 10 times greater than the lesser dose.

Incremental increases in dose that yield a vast improvement in response is a phenomenon that usually happens with drugs that attack a target molecule at multiple sites, an effect known as cooperative binding. Yet HIV has only one site that drugs can latch onto, so more of a drug shouldn’t necessarily be more effective.




Fig: The dose required to kill 50 percent of target molecules is 1 (dotted line) for both of these hypothetical HIV drugs. But the steeper slope of the red drug reveals that a very small increase in dose can have a big effect on response. Drugs that attack HIV at points in the virus’s life cycle that involve many molecules have these steep slopes, new research shows.

http://www.sciencenews.org/view/generic/id/332386/title/Varying_efficacy_of_HIV_drug_cocktails_explained

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.